These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17502793)

  • 21. Efficacy of blonanserin in combination therapy for treatment-resistant depression.
    Kumagai R; Ichimiya Y
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):593-4. PubMed ID: 19659567
    [No Abstract]   [Full Text] [Related]  

  • 22. Emerging drugs for major depressive disorder.
    Kennedy SH; Rizvi SJ
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological markers and depression.
    Mackey I
    Adv NPs PAs; 2013 Aug; 4(8):29-30. PubMed ID: 23943973
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S; Leslie DL; Rosenheck RA
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galantamine as an adjunctive treatment in major depression.
    Elgamal S; MacQueen G
    J Clin Psychopharmacol; 2008 Jun; 28(3):357-9. PubMed ID: 18480702
    [No Abstract]   [Full Text] [Related]  

  • 26. Why can low doses of sulpiride counteract depression?
    Okada F
    J Clin Psychopharmacol; 1995 Dec; 15(6):442-3. PubMed ID: 8748435
    [No Abstract]   [Full Text] [Related]  

  • 27. Easing the burden of treatment-resistant depression.
    J Clin Psychiatry; 2009 Feb; 70(2):273-80. PubMed ID: 19265643
    [No Abstract]   [Full Text] [Related]  

  • 28. Long term augmentation with T3 in refractory major depression.
    Kelly TF; Lieberman DZ
    J Affect Disord; 2009 May; 115(1-2):230-3. PubMed ID: 19108898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychiatry revisited.
    Dean CE
    Minn Med; 2008 Mar; 91(3):41-5. PubMed ID: 18438086
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel treatments for major depressive disorder.
    Lydiard RB
    CNS Spectr; 2009 Mar; 14(3 Suppl 5):11-3. PubMed ID: 19407718
    [No Abstract]   [Full Text] [Related]  

  • 31. Antidepressant dose reduction and the risk of relapse in major depressive disorder.
    Papakostas GI; Perlis RH; Seifert C; Fava M
    Psychother Psychosom; 2007; 76(5):266-70. PubMed ID: 17700046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [How do Argentinean psychiatrists treat depression?].
    Leiderman EA; Nemirovsky M; Elenitza I; Jufe G; Levin S; Mazaira S; Mussa A; Wikinski S
    Vertex; 2007; 18(75):335-43. PubMed ID: 18273418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
    Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
    J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of the use of antidepressants in children and adolescents.
    Tandon M; Pruett JR
    Mo Med; 2008; 105(1):79-84; quiz 84-5. PubMed ID: 18300611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
    Sarris J; Kavanagh DJ; Deed G; Bone KM
    Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.
    Jazayeri S; Tehrani-Doost M; Keshavarz SA; Hosseini M; Djazayery A; Amini H; Jalali M; Peet M
    Aust N Z J Psychiatry; 2008 Mar; 42(3):192-8. PubMed ID: 18247193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upping the ante on antidepressants.
    Malhi GS
    Bipolar Disord; 2008 Dec; 10(8):975-8. PubMed ID: 19594513
    [No Abstract]   [Full Text] [Related]  

  • 38. Understanding placebo response in pediatric depression trials.
    Emslie GJ
    Am J Psychiatry; 2009 Jan; 166(1):1-3. PubMed ID: 19122009
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversible paroxetine-induced symptomatic hypothyroidism.
    Takahashi M; Sawayama E; Sawayama T; Miyaoka H
    Pharmacopsychiatry; 2007 Sep; 40(5):201-2. PubMed ID: 17874352
    [No Abstract]   [Full Text] [Related]  

  • 40. Is drug-placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed?
    Rihmer Z; Gonda X
    J Affect Disord; 2008 Jun; 108(3):195-8. PubMed ID: 18280581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.